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SummAry
Cancer of the larynx in the intermediate/advanced stage still presents a major challenge in terms of controlling the disease and preserving 
the organ. Supratracheal partial laryngectomy (STPl) has been described as a function-sparing surgical procedure for laryngeal cancer 
with sub-glottic extension. The aim of the present multi-institutional study was to focus on the indications and contraindications, both local 
and general, for this type of surgery based on the long-term oncological and functional results. We analysed the clinical outcomes of 142 
patients with laryngeal cancer staged pT2-pT4a who underwent STPl. Five-year overall survival (oS), disease-specific survival (DSS), 
disease-free survival (DFS) and loco-regional control (lrC) rates were: glottic pT2 [71.4%, 95.2%, 76.0%, 76.0%], glottic–transglottic 
pT3 [85.3%, 91.1%, 86.4%, 88.7%], and pT4a [73.2%, 88.1%, 52.7%, 60.7%], respectively. DFS and lrC prevalences at 5 years were 
greatly affected by pT4a staging. Five-year laryngeal function preservation (lFP) and laryngectomy free survival (lFS) were: glottic pT2 
[90.9%, 95.2%], glottic-transglottic pT3 [84.4%, 93.1%], and pT4a [63.7%, 75.5%], respectively, being affected by pT staging and age 
65 ≥ years (lFP 54.1%). As a result of Type iii open horizontal partial laryngectomies (oPhls) (supratracheal laryngectomies), the typical 
subsites of local failure inside the larynx were the mucosa at the passage between the remnant larynx and trachea, the mucosa at the level 
of the posterior commissure and the contralateral cricoarytenoid unit as well as outside the larynx at the level of the outer surface of the 
remnant larynx. For patients with glottic or transglottic tumours and with sub-glottic extension, the choice of STPl can be considered to be 
effective, not only in prognostic terms, but also in terms of functional results.
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riASSunTo 
Il cancro della laringe in fase intermedio / avanzata rappresenta ancora una grande sfida in termini di controllo della malattia e di preser-
vazione d’organo. La laringectomia parziale sopratracheale  (STPL) è stata descritta come procedura chirurgica di function-sparing  per il 
cancro della laringe con estensione sub-glottica. Lo scopo del presente studio multi-istituzionale è di concentrarsi sulle indicazioni e con-
troindicazioni, sia locali che generali, per questo tipo di chirurgia sulla base dei risultati oncologici e funzionali a lungo termine. Abbiamo 
analizzato i risultati clinici di 142 pazienti con cancro della laringe in stadio pT2-pT4a sottoposti  a STPL. A cinque anni i tassi di sopravvi-
venza globale (OS), di sopravvivenza  malattia specifica (DSS), di sopravvivenza libera da malattia (DFS) e di controllo loco-regionale (LRC) 
sono risultati rispettivamente:  pT2 glottici [71,4%, 95,2%, 76,0%, 76,0%] , pT3 glottici-transglottici [85,3%, 91,1%, 86,4%, 88,7%], e pT4a 
[73,2%, 88,1%, 52,7%, 60,7%]. La DFS ed il LRC a 5 anni sono risultati fortemente influenzati dallo stadio pT4a. A cinque anni i tassi di 
conservazione della funzione laringea (LFP) e la sopravvivenza libera da laringectomia (LFS) sono risultati: pT2 glottici [90,9%, 95,2%], 
pT3 glottici-transglottici [84,4%, 93,1%] e pT4a [63,7%, 75,5%], risultando negativamente influenzati dal pT staging e dall’età di 65 ≥ anni 
(LFP 54,1%). A seguito di laringectomia parziale sopratracheale le sedi tipiche di recidiva sono risultate all’interno della laringe la mucosa 
al passaggio fra laringe residua e trachea , la mucosa a livello della commissura posteriore, l’unità cricoaritenoidea controlaterale e all’ester-
no la superficie esterna della laringe residua. Per i casi di tumore glottico con estensione subglottica o di tumore con importante estensione 
transglottica, la scelta di una STPL può essere considerata efficace, non solo in termini prognostici, ma anche in termini di risultati funzionali.
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Introduction
The subglottic extent of a glottic or transglottic tumour is 
often difficult to detect preoperatively, has a large propen-
sity for extralaryngeal spread and poor prognosis, espe-
cially when adopting conservative therapeutic protocols 
such as chemoradiotherapy, transoral laser surgery or 
open partial laryngectomy 1-3.
in 1972, italo Serafini 4 reported a new type of open partial 
laryngectomy called tracheohyoidoepiglottopexy aimed at 
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managing laryngeal cancer with subglottic extension: this 
procedure entailed the preservation of the suprahyoid epi-
glottis as well as the pexy of the hyoid bone and the residual 
epiglottis to the first tracheal ring. Because of removal of 
both arytenoids, the resulting functional outcomes were poor 
and Serafini abandoned this technique in the early 1980s.
in the 1990s, laccourreye et al. 5 applied a modification of con-
ventional supracricoid partial laryngectomy (SCPl), remov-
ing the cricoid ring in the case of glottic tumours with anterior 
sub-glottic extension: this has opened the way for “functional” 
supratracheal partial laryngectomies (STPl), whose current 
version was described in 2006 by rizzotto et al. 6
nowadays, STPl involves resection of the entire glottic 
and subglottic sites along the thyroid cartilage, sparing 
both or at least one functioning cricoarytenoid unit (i.e. 
half of the posterior cricoid plate, with the corresponding 
arytenoid and the intact inferior laryngeal nerve on the 
same side). inferiorly, the limit of resection encompasses 
the cricoid reaching the first tracheal ring.
recently, the european laryngological Society proposed 
a classification of the more commonly adopted proce-
dures according to the extent of resection  7, including 
three types of oPhl: Type i – supraglottic, Type ii – su-
pracricoid, and Type iii – supratracheal.
in our practice, oPhl Type iii expands the indications 
suggested by the national Comprehensive Cancer net-
work (nCCn) and the italian head and neck Society 
(ihnS) guidelines for the treatment of laryngeal cancer 
with conservative surgery (T1–T2, n0 or selected T3): 
some problematic glottic cT3 (i.e. sub-glottic extension 
and cricoarytenoid joint invasion) and some large glot-
tic-transglottic cT3 now became manageable by oPhl, 
showing promising oncological and functional results 8 9. 
With great caution, the same practice can be considered to 
be an upfront option in a very limited number of cT4a cas-
es, with minimal anterior extralaryngeal extension, when 
it is reasonable to expect an exclusive treatment.
The aim of the present study is to focus on the indications 
and contraindications, both local and general, for this type 
of surgery. A multicentric retrospective outcome analysis 
of 142 patients, suffering from glottic/transglottic laryn-
geal squamous cell carcinoma (SCC) with subglottic ex-
tension in intermediate/advanced stage, was carried out 
over a 10-year period during which organ-preservation 
protocols with chemoradiotherapy or total laryngectomy 
were applied as conventional therapeutic options for these 
types of locally advanced tumours.
Materials and methods
Patients
All patients were from the hospital of vittorio veneto, Tre-
viso, the martini hospital of Turin, the San raffaele hospital 
of milan, and the Policlinico hospital of modena. Selection 
was based on clinical and radiologic evaluation performed 
within 3 weeks of surgery, to evaluate the superficial and 
depth extent of the tumour, as previously described 10.
inclusion criteria were histological diagnosis of inter-
mediate/advanced stage glottic or transglottic laryngeal 
SCC 8, laryngeal chondrosarcoma 11 or other rare tumours, 
and a karnofsky index 12 higher than 80.
The tumours were glottic in 113 patients and transglot-
tic in 29 patients. vocal fold mobility was: 31 cases with 
normal or impaired vocal cord mobility (22 glottic pT2, 
9 supraglottic pT4a), 52 cases with fixed vocal cord and 
mobile cricoarytenoid joint (10 transglottic pT3, 3 su-
praglottic pT4a, 16 glottic-subglottic pT3, and 23 glottic 
pT4a) and 59 cases with fixed vocal cord and cricoaryt-
enoid joint (7 transglottic pT3, 31 glottic-subglottic pT3, 
and 21 glottic pT4a).
exclusion criteria were severe diabetes mellitus, severe 
bronchopulmonary chronic obstructive disease, neurolog-
ical problems impairing the ability to expectorate and/or 
swallow, or severe cardiac disease. Advanced age, an im-
portant cut-off for relative surgical indication 13, was not 
considered, in itself, an exclusion criterion.
Surgery
After informed consent had been obtained, 142 patients 
were selected to undergo Type iii oPhl between August 
29, 2002 and December 28, 2012.
Despite the fact that most of these cases had already been 
included elsewhere 9, the preoperative and intraoperative 
records, and pathological reports were reviewed to allow 
proper reclassification of these cases according to the 
2002 Tnm classification system 14.
Forty-eight patients (33.8%) included in the present analy-
sis had been treated previously for laryngeal carcinoma by 
Co
2
 transoral laser surgery (27 of 142; 19.0%), (chemo)-
radiation therapy (12 of 142; 8.5%), open partial laryngec-
tomy (4 of 142; 2.8%), or cordectomy (5 of 142; 3.5%).
Accordingly to the european laryngological Society 
Classification  7, only Type iii oPhls were performed, 
where “+CAu” represents the removal of one cricoaryt-
enoid unit: Type iiia (supratracheal partial laryngectomy/
tracheo-hyoido-epiglottopexy)  =  13 (9.2%), Type iiia 
+ CAu  =  108 (76.1%), Type iiib (supratracheal partial 
laryngectomy/tracheo-hyoido-pexy)  =  7 (4.9%), Type 
iiib + CAu = 14 (9.9%). in all patients, resection mar-
gins were examined intraoperatively with frozen sections: 
when positive, the resection was expanded until margins 
were negative. The margins of the surgical specimen were 
always checked again upon definitive pathology.
neck dissection (nD), graded according to the American 
Academy of otolaryngology-head and neck Surgery 
Foundation classification 15, was performed in 101 patients 
(71.1%) and was monolateral in 56 (55.4%) and bilateral 
in 45 (44.6%) cases. nD was elective (nD levels ii–iv) 
in 90 cn0 patients (63.4%), and curative (nD levels ii-v 
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+ internal jugular vein in one case) in 11 cn > 0 patients 
(7.7%). in 67 patients, whole level vi or unilateral para-
tracheal lymph node clearance was added. no nD was 
performed in an additional 41 patients (28.9%) (elderly 
and/or cn0 disease or in previously treated neck).
Postoperative care and adjuvant treatments
All patients were monitored for early complications (lo-
cal and general) and late sequelae. Apart from those with 
serious early complications, patients underwent the same 
rehabilitation protocol, which included: (1)  insertion of 
an uncuffed tracheal cannula and beginning of phonation 
(days 1 to 4); (2) intermittent occlusion of the tracheostomy 
with saline-soaked gauze and starting of feeding without 
the tracheal cannula in position (days 4 to 6); (3) nasogas-
tric (ng) tube removal as soon as a good level of swal-
lowing of both solids and liquids had been achieved (day 6 
onwards) 12. Postoperative aspiration was graded in accord-
ance with Pearson’s scale 16 (0 = none; i = occasional cough 
but no clinical problems; ii  =  constant cough worsening 
with meal or swallowing; iii =  pulmonary complications).
Adjuvant treatments
on the basis of pathological findings (pn+ and/or extra-
capsular spread (eCS), large extralaryngeal extent), 41 
patients (28.9%) were subjected to adjuvant radiotherapy. 
The indications for adjuvant therapy were: 13 n+ (8 level 
vi n+ and 5 pn2) and 28 cases with extralaryngeal extent 
(9 supraglottic pT4a and 19 glottic pT4a).
A large volume encompassing the primary site and all 
draining lymph nodes was irradiated with a dose of up to 
54 gy/2 gy. regions at higher risk for malignant dissemi-
nation received a 12-gy boost (total 66 gy/2 gy – range 
62–68 gy). Six of 41 patients (level vi- Delphian node 
pn+ and pn2 with eCS, and pT4a showing close margins 
toward pre-laryngeal tissues) also received 100 mg/m2 cis-
platin on days 1, 22 and 43 of the course of radiotherapy 17.
Statistical methods
overall survival (oS), disease-specific survival (DSS), 
disease-free survival (DFS), loco-regional control (lrC), 
local control (lC), laryngectomy-free survival (lFS) and 
laryngeal function preservation (lFP) were assessed by 
kaplan–meier curves. log-rank and gehan-Breslow-
Wilcoxon tests (for early events) were used to compare 
kaplan–meier estimates between groups (staging, clini-
cal history of previous treatment, and age). The corre-
sponding incidences were evaluated by chi-squared tests. 
The endpoints considered were obtained as the length of 
time from the date of diagnosis to: oS – the date of death; 
DSS – the date of death from the disease; DFS – the date 
of the first recurrence; lrC – the date of the first loco-
regional recurrence; lC – the date of the first local recur-
rence; lFS – the date of total laryngectomy; lFP – the 
date of total laryngectomy or presence of tracheostomy, 
ng tube, gastrostomy feeding, or non-intelligible voice.
All analyses were performed with graphPad Prism ver-
sion 6.0c (graphPad Software, San Diego CA, uSA), 
with p < 0.05 as the statistically significant cut-off.
Results
Patients
in total, 148 patients undergoing STPls were initially 
included in this study. After excluding those treated for 
non-SCC, a cohort of 142 patients undergoing Type iii 
oPhls was considered. Current or former smokers made 
up 92% of the cohort. Patients were followed for a mean 
period of 3.29 years.
Pathology
All patients suffered from a biopsy-proven glottic or trans-
glottic laryngeal SCC, which was classified as pT2, pT3 or 
pT4a, according to the 2002 Tnm classification system 14. 
Furthermore, pathology reports indicated close margins 
(<  2  mm) in 13 cases (9.1%), and positive margins were 
not found in any case at definitive histopathologic examina-
tion. one hundred and thirty-one patients (92.3%) had been 
staged as cn0 by palpation and neck CT scan or mri. over-
all, lymph node metastases were detected in 13/142 patients 
(9.1%), of whom 5 (3.5%) had multiple metastases.
Survival and disease control
The 5-year oS, DSS, DFS, lrC, and lC were 78.7%, 
90.4%, 69.1%, 73.8% and 80.6%, respectively (Fig. 1). At 
last follow-up, a total of 24 patients had died, of whom 12 
had died from the cancer under study.
Chart data stratification
locally intermediate/advanced laryngeal carcinomas 
differ greatly in surgical indications and prognosis. The 
analyses were hence conducted on the basis of pathologi-
cal staging to obtain homogeneous prognostic data. By 
stratifying the chart data, we evaluated whether pT, previ-
ous treatment, or age could affect the DSS, DFS, or lrC 
end points in terms of prevalence (Fig. 2).
We found that none of the factors affected DSS at 5 years. 
indeed, the 5-year DSS of pT2 tumours was 95.2%, while 
those of pT3 and pT4a SCC were 91.1 and 88.1%, respec-
tively. Similarly, the 5-year DSS of previously-treated pa-
tients was very comparable to that of untreated patients 
(91.2 and 90.5%, respectively). Finally, slight differences 
in DSS outcome, although not statistically significant, 
were found between older and younger patients (88.2 and 
91.2%, respectively).
DFS and lrC prevalence at 5 years were greatly affected 
by local staging. Despite pT2 and pT3 carcinomas dis-
playing comparable DFS prevalence (76.0 and 86.4%, 
respectively), the 5-year DFS of pT4a tumours was on-
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ly 52.7% (p < 0.05); the same pattern was also evident 
for the lrC endpoint: 76.0% in pT2, 88.7% in pT3, but 
64.8% in pT4a patients. otherwise, the clinical history of 
previous treatment or age did not affect the 5-year rates 
of DFS and lrC. in fact, DFS and lrC were 61.0% and 
73.2% in pre-treated patients, whereas they were 71.3 and 
74.5%, respectively, in patients undergoing oPhl Type 
iii as primary surgery. Similarly, age did not correlate 
with DFS and lrC: older patients had a prevalence of 
67.3% for DFS and 72.3% for lrC, while younger ones 
had a prevalence of 70.6 and 74.7%, respectively.
Finally, in terms of incidence, the overall analyses of the 
endpoints considered are reported in Table i.
Patterns of failure
loco-regional recurrences affected 30 patients within 5 
years from surgery. According to the site of pathology, 
they were sub-grouped as 21 local (70.0%) and 9 regional 
(30.0%) recurrences. local recurrences were observed in 
13 (13.8%) untreated and 8 (16.7%) pre-treated patients. 
Among these, 3 had subglottic extension and inclusion of 
a cricoarytenoid joint, 1 had surface extension as far as 
the inferior edge of the cricoid ring, 14 had extralaryngeal 
extension (9 anterior, 5 posterior) and 3 showed surface 
extension toward the posterior commissure.
inside the larynx, the typical subsites of local failure were 
the mucosa at the passage between the remnant larynx 
and trachea, the mucosa at the level of the posterior com-
missure and the contralateral CAu as well as outside the 
larynx at the level of the outer surface of the remnant lar-
ynx (probably one of these options: in transit metastasis, 
lymph node metastasis at the level of Berry’s ligament, di-
rect invasion of the thyroid gland). The most frequent site 
of close margins was the posterior commissure mucosa.
in all patients with local recurrence, salvage therapy in-
cluded total laryngectomy and adjuvant radiation therapy 
and/or chemotherapy in 17 patients, and laser surgery in 
four cases. one patient was lost to follow-up, seven pa-
tients died of laryngeal cancer from progression of disease 
Fig. 1. overall survival, disease-specific survival, disease-free 
survival, loco-regional control and local control over a 5-year 
period in 142 patients with laryngeal cancer staged pt2–pt4a 
who underwent supratracheal partial laryngectomy.
Table I. Incidence of disease-specific survival (DSS), disease-free surviv-
al (DFS) and loco-regional control (LRC) in terms of local staging, previous 
treatment and age.
Patients DSS DFS LRC
pT
pT2 22/142 21/22 (95.5%) 17/22 (77.3%) 17/22 (77.3%)
pT3 58/142 54/58 (93.1%) 51/58 (87.9%) 52/58 (89.7%)
pT4a 62/142 56/62 (90.3%) 40/62 (64.5%)* 43/62 (69.4%)*
Previous treatment
Untreated 94/142 87/94 (92.6%) 72/94 (76.6%) 75/94 (79.8%)
Treated 48/142 44/48 (91.7%) 36/48 (75.0%) 37/48 (77.1%)
Age (years)
< 65 97/142 90/97 (92.8%) 76/97 (78.4%) 78/97 (80.4%)




(average 14.0 months, range 7.4–34.1 months) and three 
patients died of other disease, while at the last follow-up, 
three patients were alive with disease and seven patients 
were alive and disease-free; overall local control after sal-
vage therapy was achieved in 7 of 21 patients (33.3%), 
and at 3 years the local control rate was 66.6%.
recurrence in the neck was observed in nine cases, five 
of whom were previously classified as cn0 and four as 
cn > 0 patients. At the time of primary resection, five of 
these nine received bilateral neck dissection, and six of 
nine recurrences were observed at level vi. Five recur-
rences in the neck were treated with surgery and adjuvant 
radiation therapy and/or chemotherapy, four recurrences 
with chemotherapy, one of whom also received radiation 
therapy; three patients died due to regional recurrences 
(range 3.8–21.0 months, mean 13.7 months) while at the 
last follow-up, one patient was alive with disease and five 
patients were alive and disease-free.
Postoperative course and morbidity
overall, acute complications during hospitalisation oc-
curred in 10 of 142 patients (7.0%) (Table ii) and there 
were no perioperative deaths. The mean hospitalisation 
time for patients with acute complications was 37  ±  6 
days, which was significantly longer than that for patients 
without acute complications (25 ± 5 days; p < 0.001). late 
sequelae following discharge were observed in 40 of 142 
cases (28.2%) (Table ii). of these, 37 were successfully 
treated with transoral Co2 laser surgery (33/37, 89.2%), 
injective laryngoplasty using vox-implants, which suc-
cessfully treated dysphagia (3/37, 8.1%), or total laryn-
gectomy (1/37, 2.7%).
Laryngeal function preservation
in our patient cohort, the 5-year lFS and lFP were 85.4% 
and 75.0%, respectively. Furthermore, we evaluated 
whether lFP could be affected by local staging, presence 
of previous treatment, or age ≥ 65 years (Fig. 3). Patients 
affected by advanced pT stage or characterised by older 
age were more prone to lose laryngeal function than those 
with intermediate pT stage or younger patients (p < 0.05 
Fig. 2. disease-specific survival, disease-free survival and loco-regional control in terms of local staging, previous treatment and age 
over a 5-year period in 142 patients with laryngeal cancer staged pt2–pt4a who underwent supratracheal partial laryngectomy.
Table II. Acute postoperative complications and late sequelae.
Patients (%)
Acute complications
Cervical bleeding 1/142 (0.7%)
Wound infection 2/142 (1.4%)
Aspiration pneumonia 5/142 (3.5%)
Other 2/142 (1.4%)
Late sequelae
Laryngeal soft tissue stenosis 25/142 (17.6%)
Dyspnoea 3/142 ( 2.1%)
Aspiration pneumonia 12/142 ( 8.5%)
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and p < 0.01, respectively). in fact, functionality was main-
tained in 90.9% of pT2 and in 84.4% of pT3 patients, but in 
only 63.7% of pT4a patients. Similarly, laryngeal function 
was maintained in 83.8% of younger patients compared to 
54.2% of the elderly, a difference that can be considered to 
be an early event, which was also significant with the ge-
han Breslow Wilcoxon test (p < 0.01). Finally, lFP was not 
biased by previous treatments (not shown).
overall, aspiration pneumonia (AP) was observed in 
14/142 patients (9.9%), five cases during hospitalisation 
and 12 cases during follow-up (Table ii). Due to intense 
dysphagia and AP episodes, a temporary gastrostomy was 
required in 10 patients (7.0%); for six of these, it was 
removed within the first postoperative year. The gastros-
tomy was maintained in only four cases due to repeated 
episodes of AP and severe dysphagia for liquids. in two 
cases, total laryngectomy was proposed for persistent 
aspiration: one patient accepted this treatment while the 
second refused, preferring to keep the gastrostomy and 
maintain voice. The other two patients were subjected to 
the endoscopic procedure of injective laryngoplasty using 
a vox implant, which successfully resolved the dysphagia, 
allowing gastrostomy removal.
Discussion
The basic goal of a partial intervention on the larynx is 
to obtain loco-regional control of the disease, sparing la-
ryngeal functions  18-20. To this end, surgery offers either 
transoral excision of the neoplasm, usually by carbon di-
oxide laser 21, or open neck partial, “functional” laryngec-
tomies 22 23, the greater part of which, especially in europe, 
is represented by open horizontal partial laryngectomies 
(oPhl). literature addressing this topic is rich, and a 
number of surgical procedures have been described to 
cope with the different patterns of endolaryngeal tumour 
site and spread 8 22-25. Schematically, among the currently 
available surgical options, total laryngectomy (Tl) 26 and 
oPhl Type  ii  27 are the more established solutions for 
intermediate-advanced stage laryngeal tumours affecting 
the glottis. however, in an attempt to tailor therapeutic 
choice to a number of variables related to the tumour and 
the patient, a significant number of lesions are not amena-
ble to be treated safely by oPhl Type ii: (i) glottic/trans-
glottic tumours with subglottic extension when the lesion 
reaches the cricoid (anteriorly, the cricoid ring is about 
15 mm from the glottis while posteriorly, the cricoid plate 
is about 5-8 mm from the vocal folds); (ii) glottic/trans-
glottic T4a because of extralaryngeal progression through 
the caudal end of the thyroid cartilage and/or through the 
cricothyroid membrane.
in this study, we considered 142 patients affected by ii–
iv staged laryngeal SCC undergoing oPhl Type iii, 
which allows safer resection of subglottic extended le-
sions 8 9. Because of their superficial involvement of the 
cricoid, glottic-subglottic pT2 are characterised by nor-
mal or impaired vocal cord mobility. The latter can be 
advantageously treated by a Co
2
 laser resection 21, or by 
oPhl Type ii 23, by removing the mucosa from the cri-
coid cartilage. in both cases, the deep margin could be 
close, but is often safe. Conversely, despite the fact that 
oPhl Type iii might seem an overtreatment due to the 
resection of the corresponding part of the cricoid, we must 
remember that posterior subglottic lesions are difficult to 
manage with any surgical solution. in the absence of car-
tilage involvement, non-surgical treatment should always 
be taken into serious consideration 28 29.
The glottic/transglottic pT3 category with subglottic ex-
tension represents the actual core group for oPhl Type 
iii. The clinical feature most often characterising these 
tumours is vocal cord and arytenoid fixation with cricoar-
ytenoid joint and cricothyroid space involvement, com-
bined with arytenoid and/or cricoid sclerosis. The choice 
of an oPhl Type ii procedure would result in a greater 
risk of positive margins. The introduction of oPhl Type 
iii has opened a useful window into function sparing 
surgical protocols. in fact, open neck partial surgery can 
now be conducted using the principles of a modular ap-
proach. This states that the resection is always prepared in 
standard mode and the larynx is opened from the side less 
affected by disease. Sub-sites involved are removed and 
the resection can be easily enlarged as follows: oPhl 
Type ii +Ary → oPhl Type iii +CAu, oPhl Type 
iiia/b → oPhl Type iiia/b +CAu, oPhl Type iii/a → 
oPhl Type iii/b. resection margins must be examined 
with frozen sections: if positive, the resection can be ex-
Fig. 3. Laryngeal function preservation in terms of local staging, previous treatment and age over a 5-year period in 142 patients 
with laryngeal cancer staged pt2–pt4a who underwent supratracheal partial laryngectomy.
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panded until free margins are achieved. The systematic 
application of whole organ sections represents the quality 
control for both the surgical procedure and imaging ac-
curacy. it demonstrates that the more extirpative oPhl 
Type iii is mandatory for cancers affecting the cricothy-
roid space and reaching the upper limit of the cricoid. 
in these cases, an oPhl Type ii would almost certainly 
result in a positive margin along the upper border of the 
cricoid. in the present study for pT3, the 5-year oS and 
DSS were 85.3 and 91.1%, respectively, which are better 
than what was previously reported for both concomitant 
chemoradiotherapy or induction chemotherapy and ra-
diotherapy (~60%) 26 29.
more advanced pT4a tumours require a series of consid-
erations: first, it must be noted that, in all of the cases in 
the present cohort, the extralaryngeal extent was minimal. 
The second is the widespread agreement that total laryn-
gectomy would be the elective intervention for a tumour 
with extralaryngeal spread, which occurs almost always 
through invasion of the laryngeal framework. oPhl Type 
iii results have demonstrated that a careful selection can 
make a good number of patients eligible, even in a few 
very well selected “extreme cases”. Treating anterior cT4a 
tumours (full-thickness involvement of the thyroid lamina 
and/or minimal extralaryngeal extension) by oPhl re-
quires an absolutely comparable radicality to that result-
ing from total laryngectomy. At the end of the work-up, 
the surgeon must be able, as much as possible, to ensure 
safe margins thus avoiding an upfront total laryngectomy. 
As the elective indication in these cases is extirpative sur-
gery, patients should be driven by a strong desire to avoid 
total laryngectomy and must be informed in advance. 
Adopting these selection criteria in pT4a cases, oPhl 
Type iii displayed 5-year oS and DSS of 73.2 and 88.1%, 
respectively, which are in line with those achievable with 
total laryngectomy. however, the DFS for pT4a cancer 
(52.7%) was significantly lower than that for pT3 cases 
(86.4%), but higher in comparison to what was obtained 
by radiotherapy and/or chemoradiotherapy management 
(26 to 38%) 26 29. on the other hand, the absence of major 
comorbidities and the ability to undergo a rigorous post-
operative rehabilitation represent general prerequisites for 
all partial laryngectomies.
more attention should be given to local contraindications 
related to disease extension. oPhl Type iii is not able to 
give a sufficient radicality in: (i) lesions arising from the 
epilarynx (junction zone between the supraglottic larynx 
and the other regions); (ii)  lesions with major invasion 
of the preepiglottic space involving the hyoid bone, the 
interarytenoid space, the posterior commissure and both 
arytenoid cartilages; (iii)  large extralaryngeal spread of 
cancer; and (iv) lesions reaching the first tracheal ring.
larynx function preservation has substantial advantages 
in tailoring surgery to the actual extent of the tumour. its 
maintenance was more critical in patients affected by pT4a 
cancer (63.7%) and in those older than 65 years (54.2%).
Persistent slight dysphagia and aspiration pneumonia still 
represent major complications in patients undergoing 
oPhls 20 25 30-31, while voice was significantly deteriorat-
ed, and generally quite hoarse and breathy 9. Fortunately, 
these phenomena are infrequent, tend to be easily con-
trolled and are well tolerated by patients.
in cases indicated for a more extreme oPhl Type iii, ethi-
cal considerations can arise. in fact, these cases are con-
sidered “amenable with total laryngectomy” and therefore, 
upfront directed to non-surgical treatment to spare the lar-
ynx. The patient must be clearly informed that if the re-
section margins are positive from frozen sections, the in-
tervention will be converted to a total laryngectomy, thus 
“jumping” the option of concomitant chemoradiotherapy 
(recommendation iA in the current guidelines). For these 
reasons, both the severity of the intervention and the neces-
sity for adjuvant radiotherapy demand that extreme caution 
must be taken in considering the indications.
in conclusion, we summarise the precise indications and 
contraindications for oPhl Type iii (see oPhl hand-
book in the Appendix 1). Furthermore, we demonstrate 
that the choice of a modular oPhl Type iii approach can 
be considered viable in comparison to chemoradiation 
protocols for some well-studied glottic and/or transglot-
tic tumours with sub-glottic extension. Advantages can 
be obtained in terms of prognosis (better identification of 
upstaging and reduction in prevalence of recurrence) and 
functional results such as a reduction in the number of 
total laryngectomies, even at the expense of voice quality 
and occurrences of sequelae (aspiration pneumonia).
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Type III OPHL Handbook
Local indications
As definitions for the Type iii (a+b) oPhls have only 
recently been introduced, the precise T classification 
related indications and contraindications are separately 
reported:
•	 Glottic T2 with subglottic extension
The oPhl Type iii option has been considered for tumours 
with anterior or lateral subglottic extension, spreading 
above the conus elasticus and reaching the cricoid. in all 
these cases, vocal cord mobility has been normal or im-
paired, while arytenoid mobility has always been normal.
As a rule, the lesion has shown a superficial subglottic 
extension, more than 10 mm anteriorly and about 5–8 mm 
posteriorly.
The CT scan shows a glottic lesion extending downward, 
apparently without involvement of the cricothyroid space 
and/or extension through the cricothyroid membrane, and 
which reaches the cricoid plate posteriorly and/or the 
cricoid ring anteriorly. There is no evidence of direct in-
volvement of the laryngeal framework although it is pos-
sible to highlight sclerosis of the arytenoid or the cricoid 
cartilage, indirect signs of the lesion reaching the carti-
lage perichondrium (Fig. S1 a-c).
•	 Glottic/transglottic T3 with subglottic extension
This category is extremely heterogeneous and the major-
ity of lesions are manageable with an oPhl Type ii (su-
pracricoid laryngectomy). in these cases, the most evident 
clinical feature is the fixed vocal cord with mobile aryt-
enoid, a sign of no invasion of the cricoarytenoid joint.
oPhl type iii was essentially adopted in two situations:
A. glottic-subglottic T3 tumours spreading within the 
paraglottic space and controlled by the conus elasticus 
medially and the perichondrium of the thyroid carti-
lage laterally (Fig. S2 a-d) (tumour growth is directed 
downward and laterally; sometimes it can infiltrate the 
inferior edge of the thyroid cartilage or exit the larynx 
between the thyroid and cricoid cartilages through the 
cricoarytenoid membrane: the so-called early glot-
tic pT4a) (Fig. S3 a-c). Surface extension toward the 
posterior commissure can be observed. Typical clinical 
features are the fixed vocal cord, fixed arytenoid and 
subglottic swelling.
Fig. S1. a-b) ct scan in axial view of right recurrent glottic t2 
with impaired mobility of the vocal cord, extending superficially 
to the subglottic site along the elastic cone toward the cricoid 
cartilage. c) the tumour reaches the cricoid plate and ring.
Fig. S2. a-b) ct scan in axial view of left glottic t3 with fixed vocal 
cord and hypomobile arytenoid, extending downward and laterally 
within inferior paraglottic space. note the intense sclerosis of the 
arytenoid without evidence of direct invasion of the cricoid. c) the 
specimen of oPhL type iii + left cAu. d) Macrosection of the same 
specimen: the lesion reaches the crico-arytenoid joint (arrow).
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B. transglottic T3 tumours spreading superiorly into the 
deep tissue of the ventricular band under the quadran-
gular membrane and progressing into the subglottic 
area, where they reach the internal lamina and the infe-
rior edge of the thyroid cartilage or the superior edge of 
the cricoid (Fig. S4). Also in these cases, both the vocal 
cord and arytenoid can be fixed.
•	 T4a with limited anterior or lateral extralaryngeal ex-
tension
gross extralaryngeal spread of cancer represents a clear 
contraindication to any type of partial laryngectomy. how-
ever, oPhl type iii has been advantageously adopted in 
clinically T3 tumours but strongly suspected of having 
an initial extralaryngeal extension through the laryngeal 
framework or cricothyroid space/membrane (Fig. S5 a-c). 
in these cases, because of the suspicion of extralaryngeal 
extension, the radicality provided would be comparable to 
that of total laryngectomy.
Other indications
oPhl Type iii was also successfully adopted for radi-
cal resection of low-intermediate grade laryngeal chon-
drosarcomas without involvement of the whole cricoid 
plate 11 (Fig. S6) and in a case of recurrent papillary thy-
roid carcinoma with thyroid cartilage involvement and 
intralaryngeal spread (Fig. S7 a-b).
Fig. S3. a-b) Mri in axial view of left glottic t3 with fixed vocal 
cord and arytenoid, extending downward and laterally reaching 
the crico-thyroid space. note the intense sclerosis of the cri-
coid with suspect involvement of thyroid cartilage. c) Macro-
section on the specimen of oPhL type iii + left cAu: the lesion 
involves the cricothyroid space, the inferior edge of the thyroid 
cartilage and superior edge of the cricoid (arrows).
Fig. S4. ct scan in coronal view of right transglottic t3 with 
fixed vocal cord and arytenoid. the tumour clearly invades the 
superior and inferior paraglottic space with transglottic exten-
sion toward the cricoid cartilage.
Fig. S5. a) Mri in axial view of left glottic t4a with fixed vocal 
cord and arytenoid, extending downward and laterally within 
inferior paraglottic space. note the involvement of the arytenoid 
and the crico-arytenoid joint without evidence of direct invasion 
of the cricoid. b)  Anterior extralaryngeal spread through the 
thyroid cartilage. c) the specimen of oPhL type iii + left cAu.
Fig. S6. Mri in axial view of right intermediated grade larynx chon-




With respect to the local extent of the tumour, our abso-
lute contraindications were as follows:
• supraglottic T4a tumours reaching the base of the 
tongue or invading the hyoid bone (Fig. S8 a-b);
• glottic-subglottic T3 tumours with massive invasion 
of the paraglottic space reaching the posterior cricoar-
ytenoid muscle and the pyriform sinus submucosa 
(Fig. S9);
• gross glottic-subglottic T4a with massive cricoid in-
vasion (Fig.  S10) or reaching the first tracheal ring 
(Fig. S11);
• lymph nodes staged N3.
Fig. S7. a-b) Mri in coronal and axial view of recurrent papillary 
thyroid carcinoma with thyroid cartilage involvement and intra-
laryngeal spread.
Fig. S8. a-b) ct scan of supraglottic t4a tumors reaching the 
base of the tongue and involving the hyoid bone. a) Axial view. 
b) coronal view.
Fig. S9. a-b) Mri in axial and coronal view of right glottic t3 
with fixed vocal cord and arytenoid, extending posteriorly to the 
pyriform sinus submucosa and reaching the posterior commis-
sure and posterior crico-arytenoid muscles.
Fig. S10. ct scan of large glottic-subglottic t4a with massive 
cricoid invasion and extralaryngeal spread.
Fig. S11. ct scan of glottic-subglottic t4a reaching the first 
tracheal ring and with extralaryngeal spread.
